These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 14996770)
21. Tiotropium bromide. Lipson DA Int J Chron Obstruct Pulmon Dis; 2006; 1(2):107-14. PubMed ID: 18046887 [TBL] [Abstract][Full Text] [Related]
22. [After diagnosis 11 more years remain. COPD alarm in Europe!]. Wepner U MMW Fortschr Med; 2002 Oct; 144(44):12-3. PubMed ID: 12494590 [No Abstract] [Full Text] [Related]
23. [Other forms of bronchodilation]. Izquierdo Alonso JL; Malo de Molina R Arch Bronconeumol; 2004 Mar; 40 Suppl 1():23-9. PubMed ID: 16137446 [No Abstract] [Full Text] [Related]
25. The use of inhaled anticholinergics in chronic obstructive pulmonary disease: is there cause for concern of cardiovascular safety? McIvor RA Pol Arch Med Wewn; 2009 Nov; 119(11):697-8. PubMed ID: 19920792 [No Abstract] [Full Text] [Related]
27. [Long-acting bronchodilator agents are the choice in COPD. Keeping the airways open continuously]. MMW Fortschr Med; 2007 Nov; 149(47):54. PubMed ID: 18064817 [No Abstract] [Full Text] [Related]
28. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium. Good CB; Longo L Ann Intern Med; 2006 Jan; 144(2):147; author reply 148-9. PubMed ID: 16418422 [No Abstract] [Full Text] [Related]
29. Does tiotropium reduce hospitalizations in chronic obstructive pulmonary disease? Oba Y Ann Intern Med; 2008 Apr; 148(8):626; author reply 626-7. PubMed ID: 18413628 [No Abstract] [Full Text] [Related]
30. ACP Journal Club. Review: In COPD, tiotropium improves lung function and reduces adverse events compared with ipratropium bromide. Maselli DJ; Peters JI Ann Intern Med; 2016 Jan; 164(2):JC6. PubMed ID: 26784496 [No Abstract] [Full Text] [Related]
31. Tiotropium and the treatment of chronic obstructive pulmonary disease. Anthonisen NR Can Respir J; 2007; 14(8):460-2. PubMed ID: 18257166 [No Abstract] [Full Text] [Related]
32. Is sustained pharmacologic lung volume reduction now possible in COPD? O'Donnell DE Chest; 2006 Mar; 129(3):501-3. PubMed ID: 16537841 [No Abstract] [Full Text] [Related]
33. Tiotropium: a new, long-acting agent for the management of COPD--a clinical review. Crutchfield D Director; 2004; 12(3):160, 162-4. PubMed ID: 15323298 [TBL] [Abstract][Full Text] [Related]
34. Tiotropium: a potential replacement for ipratropium in patients with COPD. Shukla VK Issues Emerg Health Technol; 2002 Jul; (35):1-4. PubMed ID: 12195603 [TBL] [Abstract][Full Text] [Related]
37. [Can tiotropium bromide favorably influence the course of disease?]. Stiefelhagen P Med Monatsschr Pharm; 2006 Aug; 29(8):308-9. PubMed ID: 16927602 [No Abstract] [Full Text] [Related]
38. Tiotropium; more knowledge leads to more questions. Singh D Int J Chron Obstruct Pulmon Dis; 2008; 3(1):i-ii. PubMed ID: 18488424 [No Abstract] [Full Text] [Related]
39. Evaluation of the efficacy and safety of tiotropium bromide (5 µg) inhaled via Respimat in Chinese patients with chronic obstructive pulmonary disease. Tang Y; Massey D; Zhong NS Chin Med J (Engl); 2013; 126(19):3603-7. PubMed ID: 24112149 [TBL] [Abstract][Full Text] [Related]
40. [Tiotropium bromide in the treatment of chronic obstructive lung disease]. Shmelev EI Ter Arkh; 2003; 75(12):69-72. PubMed ID: 14959476 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]